Objective:

To discuss equitable access to genomic testing and the systemic changes urgently needed to improve rare disease diagnostics.

Key Findings:

• Rare diseases affect over 300 million people globally, with significant disparities in access to genomic testing, particularly in underserved regions.
• Long-read sequencing reveals a higher mutation rate than previously estimated, aiding in understanding rare disease prevalence and improving diagnostic accuracy.
• Current diagnostic pathways are inefficient, often leading to inconclusive results and prolonged patient burden, with more than half of rare disease cases remaining unsolved.
• Systemic barriers, such as limited access and long wait times, hinder the diagnostic process despite technological advancements, particularly in low-resource settings.

Interpretation:

Improving access to genomic testing and utilizing long-read sequencing can significantly enhance diagnostic outcomes for rare diseases, addressing both scientific and systemic challenges that currently impede progress.

Limitations:

• Access to genomic testing varies widely across regions, with some areas lacking necessary infrastructure, which directly impacts patient outcomes.
• More than half of rare disease cases remain unsolved despite advances in technology, highlighting the need for improved diagnostic pathways.

Conclusion:

Addressing both technological and accessibility barriers is crucial for shortening the diagnostic odyssey and improving patient outcomes in rare diseases, necessitating systemic change.